<DOC>
	<DOCNO>NCT00005183</DOCNO>
	<brief_summary>To define linkage Apo A-I gene polymorphism genetic high density lipoprotein ( HDL ) deficiency premature coronary artery disease . Also , utilize gene marker define prevalence genetic HDL deficiency patient premature coronary disease determine relative risk premature coronary disease associate Apo A-I gene polymorphism .</brief_summary>
	<brief_title>Apolipoprotein A-I Gene Polymorphism Atherosclerosis</brief_title>
	<detailed_description>BACKGROUND : Apolipoprotein ( apo ) A-I major protein constituent plasma high density lipoprotein ( HDL ) . HDL show promote cholesterol efflux cell vitro . Decreased plasma concentration HDL cholesterol Apo A-I associated premature coronary artery disease due atherosclerosis society . A genetic HDL deficiency , familial hypoalphalipoproteinemia , appear fairly common patient premature coronary artery disease . The gene Apo A-I isolate characterize . Preliminary study indicate specific Apo A-I gene polymorphism , detect follow Pst I restriction enzyme digestion utilize specific probe , significantly common subject premature coronary artery disease normal control subject , kindred associate genetic HDL deficiency . This Apo A-I gene polymorphism due alteration Apo A-I , Apo C-III intergenic region , near 3 ' end cod region Apo A-I . These observation important implication detection individual genetically predispose premature coronary disease , well provide insight mechanism lead atherosclerosis . DESIGN NARRATIVE : Questionnaires use obtain information patient know risk factor diet . Fasting blood sample obtain lipoprotein analysis . Standard clinical cardiological information fast blood sample also collect case . Blood drawn DNA study . A determination make whether Pst I Apo A-I gene polymorphism associate diminished level plasma Apo A-I HDL cholesterol , analysis distribution variable case control , control know risk factor . Linkage analysis use determine whether Pst I Apo A-I gene polymorphism co-segregates premature coronary disease , diminish level plasma Apo A-I , HDL cholesterol 50 kindred . A characterization make abnormality Apo A-I , Apo C-III , Apo A-IV gene complex patient HDL deficiency , premature coronary disease , Pst I Apo A-I gene polymorphism .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2000</verification_date>
</DOC>